Favorable Course of Pericardial Angiosarcoma Under Paclitaxel Followed by Pazopanib Treatment Documented by Cardiovascular Magnetic Resonance Imaging

Saved in:
Bibliographic Details
Published inCirculation (New York, N.Y.) Vol. 126; no. 18; p. e279
Main Authors Ong, Peter, Greulich, Simon, Schumm, Julia, Backes, Maik, Kaufmann, Martin, Bode-Erdmann, Sabine, Ott, German, Hebart, Holger, Mahrholdt, Heiko
Format Journal Article
LanguageEnglish
Published United States 30.10.2012
Subjects
Adrenal Cortex Hormones - administration & dosage
Adult
Angiogenesis Inhibitors - administration & dosage
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Delayed Diagnosis
Diagnostic Errors
Doxorubicin - administration & dosage
Drug Resistance, Neoplasm
Etoposide - administration & dosage
Heart Neoplasms - complications
Heart Neoplasms - diagnosis
Heart Neoplasms - drug therapy
Heart Neoplasms - pathology
Hemangiosarcoma - complications
Hemangiosarcoma - diagnosis
Hemangiosarcoma - drug therapy
Hemangiosarcoma - pathology
Humans
Ifosfamide - administration & dosage
Lymphoma, Non-Hodgkin - diagnosis
Magnetic Resonance Imaging
Male
Myocardium - pathology
Paclitaxel - administration & dosage
Pericardial Effusion - diagnosis
Pericardial Effusion - etiology
Pericardial Effusion - pathology
Pericardiocentesis
Pericarditis - diagnosis
Pericardium - pathology
Protein Kinase Inhibitors - administration & dosage
Pulmonary Embolism - etiology
Pyrimidines - administration & dosage
Remission Induction
Sulfonamides - administration & dosage
Vincristine - administration & dosage
Online AccessGet full text
ISSN0009-7322
1524-4539
1524-4539
DOI10.1161/CIRCULATIONAHA.112.128348

Cover

More Information
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Undefined-5
ObjectType-Report-1
ObjectType-Article-3
ISSN:0009-7322
1524-4539
1524-4539
DOI:10.1161/CIRCULATIONAHA.112.128348